Rankings
▼
Calendar
RCKT FY 2017 Earnings — Rocket Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RCKT
Rocket Pharmaceuticals, Inc.
$538M
FY 2017 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$204,000
Operating Income
-$27M
Net Income
-$29M
EPS (Diluted)
$-4.36
Cash Flow
Operating Cash Flow
-$26M
Free Cash Flow
-$26M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$102M
Total Liabilities
$54M
Stockholders' Equity
$48M
Cash & Equivalents
$79M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$204,000
-$169,000
-20.7%
Operating Income
-$27M
-$42M
+36.2%
Net Income
-$29M
-$43M
+31.2%
← Q4 2016
All Quarters
Q1 2017 →